ArticleCancers2023

Plasma Immune Proteins and Circulating Tumor DNA Predict the Clinical Outcome for Non-Small-Cell Lung Cancer Treated with an Immune Checkpoint Inhibitor.

Simone Stensgaard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.